ESR1 and breast carcinoma: In 1970, an estrogen receptor-positive cell line, called MCF-7, was derived from a metastatic breast cancer patient at the Michigan Cancer Foundation in 1973 [4], which has become the most extensively used model of estrogen-positive breast cancer cell line for the study of breast cancer as it relates to the susceptibility of the cells to apoptosis [5].